The wave of departures in August continued with the resignation of a group of pharmaceutical executives.

Sina Pharmaceuticals incomplete statistics, the following recent corporate executives left: Wang Hong left GlaxoSmithKline on the afternoon of August 31, GlaxoSmithKline announced to employees in China, GSK Vice President, head of the respiratory business department Wang Hong for personal reasons has decided to leave, 31 for the last working day.
Less than eight months after Wang Hong took over the post, GSK China also announced that qi Xin, GSK's vice president and general manager of prescription drugs and vaccines in China, will fully manage the respiratory business before the appointment of a new head of the respiratory business.
Wang Hong graduated from Capital Medical University with a major in paedo science and served as national sales director of Lingbei China, she joined Merca East in 2008 as national sales director of Buck Products, in 2012 joined Pfizer as national sales director of the vaccine division, and was promoted to head of Pfizer China Vaccines, and in 2016, Wang Hong left Pfizer to join BD as head of the MPS division in BD Greater China.
In January 2018, Wang Hong returned to Lingbei China as Vice President and Commercial Officer of Lingbei China Sales Marketing and Commerce, and on January 2 this year, Lingbei China announced Wang Hong's departure, with a final working day of January 10, followed by joining GSK China on January 15 as Vice President of GSK and Head of Breathing.
Zhu Chunlin and Yang Xiaojun left Essence Pharmaceuticals on August 31, Essence Pharmaceuticals issued an announcement. on August 27, 2020, the Board of Directors of
received a written resignation report from Mr. Zhu Chunlin and Mr. Yang Xiaojun, who applied to resign as a director of the Company for personal reasons, and Mr. Yang Xiaojun, who applied to resign as a director and deputy general manager of the Company for personal reasons.
Mr. Zhu Chunlin resigned from any position in the company, and Mr. Yang Xiaojun resigned and continued to serve as chairman of Bao hetang Pharmaceutical Co., Ltd., a subsidiary of the company.
In fact, Zhu Chunlin, as a former chairman, announced his resignation on April 22, 2019, resigning as chairman of the company due to his personal health and age, and resigning as a member of the nomination committee, audit committee and strategy committee of the company's fourth board of directors.
Zhu Chunlin has served as deputy director of Nantong Pesticide Factory, director of the Technical Center, general manager of Nantong Jiangshan Pesticide Chemical Co., Ltd., deputy general manager of Essence Group, deputy general manager of Nantong Industry and Trade, and chairman of Nantong Essence Pharmaceutical Co., Ltd.
In addition, a number of pharmaceutical executives left: August 28, The United States Health Industry Holdings Co., Ltd. issued an announcement, the board of directors recently received the company's vice president Mr. Zhang Shengjiang submitted a written resignation report, due to work adjustment arrangements, applied to resign as vice president of the company.
August 25, the board of directors of Xinbang Pharmaceuticals received written resignation reports from the directors of the company, Mr. Xiang Li and Ms. Xu Qi.
Xiang Li applied to resign as a director and vice chairman of the company for personal reasons, and also resigned as a member of the Strategic Committee of the Board of Directors, and Ms. Xu Qi applied to resign as a director of the company for personal reasons.
August 19, Jingfeng Pharmaceuticals said that Mr. Zhang Junguo had applied for resignation as the company's director of human resources and in various positions in the company's subsidiaries for personal reasons.
same day, Geelyde's global vice president and general manager of China, Luo Yongqing, decided to leave the company and seek external development.
August 17th, Fuzheng Pharmaceuticals announced that Mr. Sun Jilin had resigned as chairman and general manager of the company for personal reasons, effective August 10, 2020.
August 12, Beijing Lidman announced that, due to the reasons for the transfer of work, Mr. Lin Requested to resign as chairman and director of the company, and together resigned as convenor of the strategic committee of the board of directors, resigned from any position of the company.
August 11, Stepping Pharmaceuticals announced that Ms. Wang Mei had applied to resign as the company's supervisor for personal reasons and would not hold any position in the company after her resignation.
Ms. Wang Mei's resignation report will take effect when it reaches the Supervisory Board.
same day, Jiangsu Fish Leap issued a "announcement on the resignation of senior managers", which indicated that Mr. Zhao Chunsheng requested to resign as vice president (deputy general manager) of the company for personal reasons.
Mr. Zhao Chunsheng resigns, he will no longer hold any position in the company.
August 10, Tonghua Dongbao announced that Mr. Han Fengjun had applied to resign as deputy general manager of the company for personal reasons.
same day, Anhui Huangshan Capsules announced that Mr. Zhang Min had applied to resign as an independent director of the company and as a special committee under the board of directors because his term of office had expired.
August 7, the board of directors of Gansu Shenyi Pharmaceuticals received a written resignation from Mr. Qian Shuangxi, Deputy General Manager of the company.
Mr. Qian Shuangxi due to personal work changes, another appointment, applied to resign as deputy general manager of the company, Mr. Qian Shuangxi resigned will no longer hold any position in the company.
August 6, Seven Dan Pharmaceuticals announced that Mr. Zhang Hadson had resigned as the company's supervisor for personal reasons.
August 3, Nanjing Pharmaceuticals announced that Mr. Han Dong had applied to resign as a director of the 8th Board of Directors of the Company and a member of the Audit and Risk Control Committee of the Board of Directors because of the change in his work.
.